BY SIMONE J. SMITH
“We may not be able to demonstrate sufficient efficacy or safety of our COVID-19 vaccine and/or variant specific formulations to obtain permanent regulatory approval in the United States, United Kingdom, European Union or other countries where it has been authorized for emergency use or granted conditional marketing approval.” Pfizer Annual Report (Form 20-F, Page 6)
I can only imagine how sick everyone is with the vaccine debate: vaccinated, not vaccinated, passports, no passports. When is this all going to stop?
Unfortunately for us, due to the deceit of our global leaders, pharmaceutical companies and even our doctors, this vaccine situation is going to be with us for a while.
What is most disturbing is that the manufacturers themselves admit in their own exposed documents that their vaccines are dangerous, ineffective and will probably NEVER pass clinical trials in an acceptable way for an actual approval for standard use.
This information is not coming from left field. Researchers at the New York State Department of Health found that vaccine effectiveness against COVID-19 infection declined from 68% to only 12% over the period of December 13th, 2021, to January 30th, 2022. There was a notable change in the document that must be noted. Where it used to say” Undesirable Side Effects” in 2021 was upgraded to “Significant Adverse Events.”
There are some other aspects of this document that I believe our readers need to know.
TRIGGER WARNING; Readers might get a little upset after reading what was disclosed, especially because this pharmaceutical company has put us all in harm’s way. I pulled some of the major points that are straight from Pfizer’s annual report given to the SEC about the vaccine It states the following in the “Risk Factors for investors/shareholder’s section:
- Our revenue depends heavily on sales of our COVID-19 vaccine, and our future revenues from our COVID-19 vaccine are uncertain.
- Our commercial revenue is based on preliminary estimates of COVID-19 vaccine sales and costs from Pfizer Inc., or Pfizer, that are likely to change in future periods, which will impact our reported financial results.
- Significant adverse events may occur during our clinical trials or even after receiving regulatory approval, which could delay or terminate clinical trials, delay or prevent regulatory approval or market acceptance of any of our product candidates.
- We face significant competition from other makers of COVID-19 vaccines and may be unable to maintain a competitive market share for our COVID-19 vaccine.
- We have only recently built our marketing and sales organization. If we are unable to continue to increase our marketing and sales capabilities on our own or through third parties, we may not be able to market and sell our product candidates effectively in the United States and other jurisdictions, if approved, or generate product sales revenue.
- Our approved product and product candidates are based on novel technologies and they may be complex and difficult to manufacture. We may encounter difficulties in manufacturing, product release, shelf life, testing, storage, supply chain management or shipping. If we, or any of the third-party manufacturers we work with encounter such difficulties, our ability to supply materials for clinical trials or any approved product could be delayed or stopped.
The only reason we, as Canadians, patients, consumers and even vaccinated people, know this information is because Pfizer could be possibly sued by investors if they did not disclose the dangers of the vaccine, lack of safety and lack of efficacy to the Securities and Exchange Commission (SEC).
So, when our elected professionals were pushing the vaccines on Canadians and telling us that it was “Safe and effective,” were they aware of this information, and if they were not, why did such a dangerous drug become mandated? Now that they know, why are they still trying to push vaccine passports?
Community, we need to start holding our elected officials accountable. Remember this when you go to the polls on June 2nd, 2022.